Latest Insider Transactions at Liquidia Corp (LQDA)
This section provides a real-time view of insider transactions for Liquidia Corp (LQDA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Liquidia Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Liquidia Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 12
2024
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,585
-1.03%
|
$22,190
$14.58 P/Share
|
|
Apr 12
2024
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,525
-0.71%
|
$21,350
$14.58 P/Share
|
|
Apr 12
2024
|
Russell Schundler General Counsel |
SELL
Open market or private sale
|
Direct |
2,060
-0.42%
|
$28,840
$14.58 P/Share
|
|
Apr 12
2024
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,189
-1.05%
|
$16,646
$14.58 P/Share
|
|
Apr 11
2024
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,906
+3.35%
|
-
|
|
Mar 18
2024
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
4,657
-2.06%
|
$69,855
$15.66 P/Share
|
|
Mar 18
2024
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
260
+0.23%
|
-
|
|
Mar 18
2024
|
Roger Jeffs Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
28,583
-3.31%
|
$428,745
$15.82 P/Share
|
|
Mar 18
2024
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,530
-1.7%
|
$112,950
$15.82 P/Share
|
|
Mar 18
2024
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
12,166
-1.85%
|
$182,490
$15.82 P/Share
|
|
Mar 18
2024
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,108
-3.83%
|
$91,620
$15.82 P/Share
|
|
Mar 18
2024
|
Russell Schundler General Counsel |
SELL
Open market or private sale
|
Direct |
8,653
-0.87%
|
$129,795
$15.82 P/Share
|
|
Mar 15
2024
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,625
+12.14%
|
-
|
|
Mar 15
2024
|
Michael Kaseta CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+0.7%
|
-
|
|
Mar 15
2024
|
Russell Schundler General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+0.47%
|
-
|
|
Feb 29
2024
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
455
-0.46%
|
$6,370
$14.17 P/Share
|
|
Feb 29
2024
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,562
+1.57%
|
-
|
|
Feb 29
2024
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
546
-0.34%
|
$7,644
$14.17 P/Share
|
|
Feb 29
2024
|
Scott Moomaw Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+1.16%
|
-
|
|
Jan 15
2024
|
Michael Kaseta CFO and COO |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+13.29%
|
-
|
|
Jan 11
2024
|
Russell Schundler General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
110,135
+18.27%
|
-
|
|
Jan 11
2024
|
Roger Jeffs Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
221,338
+20.43%
|
-
|
|
Jan 11
2024
|
Jason Adair Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,588
+29.52%
|
-
|
|
Jan 11
2024
|
Michael Kaseta CFO and COO |
BUY
Grant, award, or other acquisition
|
Direct |
93,250
+25.24%
|
-
|
|
Jan 11
2024
|
Scott Moomaw Chief Commercial Officer |
SELL
Grant, award, or other acquisition
|
Direct |
49,723
-24.12%
|
-
|
|
Jan 11
2024
|
Rajeev Saggar Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,492
+20.39%
|
-
|
|
Dec 18
2023
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
77
-0.14%
|
$539
$7.7 P/Share
|
|
Dec 18
2023
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
261
+0.47%
|
-
|
|
Dec 18
2023
|
Rajeev Saggar Chief Medical Officer |
BUY
Open market or private sale
|
Direct |
14,887
+8.32%
|
$104,209
$7.42 P/Share
|
|
Dec 14
2023
|
Paul B Manning Director |
BUY
Open market or private purchase
|
Direct |
279,330
+50.0%
|
$1,955,310
$7.16 P/Share
|
|
Dec 14
2023
|
Roger Jeffs Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
139,665
+17.9%
|
$977,655
$7.16 P/Share
|
|
Dec 14
2023
|
Caligan Partners LP Director |
BUY
Open market or private purchase
|
Indirect |
1,117,318
+9.01%
|
$7,821,226
$7.16 P/Share
|
|
Nov 30
2023
|
Michael Kaseta CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,343
+1.26%
|
-
|
|
Nov 30
2023
|
Robert A Lippe Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
497
-0.26%
|
$3,479
$7.28 P/Share
|
|
Nov 30
2023
|
Robert A Lippe Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,718
+0.88%
|
-
|
|
Nov 30
2023
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
452
-0.82%
|
$3,164
$7.28 P/Share
|
|
Nov 30
2023
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,563
+2.75%
|
-
|
|
Nov 30
2023
|
Russell Schundler General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,343
+0.61%
|
-
|
|
Nov 30
2023
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
542
-0.51%
|
$3,794
$7.28 P/Share
|
|
Nov 30
2023
|
Scott Moomaw Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+1.72%
|
-
|
|
Sep 19
2023
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
75
-0.14%
|
$450
$6.51 P/Share
|
|
Sep 19
2023
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
260
+0.48%
|
-
|
|
Aug 31
2023
|
Michael Kaseta CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+1.28%
|
-
|
|
Aug 31
2023
|
Russell Schundler General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+0.61%
|
-
|
|
Aug 31
2023
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
537
-0.51%
|
$3,222
$6.88 P/Share
|
|
Aug 31
2023
|
Scott Moomaw Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+1.74%
|
-
|
|
Aug 31
2023
|
Robert A Lippe Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
505
-0.26%
|
$3,030
$6.88 P/Share
|
|
Aug 31
2023
|
Robert A Lippe Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,719
+0.88%
|
-
|
|
Aug 31
2023
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
445
-0.83%
|
$2,670
$6.88 P/Share
|
|
Aug 31
2023
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,562
+2.82%
|
-
|